Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Operating Results by Reportable Segment (Detail)

v3.7.0.1
Segment Information - Operating Results by Reportable Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Segment Reporting Information [Line Items]          
Net Revenue $ 50,697 $ 2,230 $ 95,379 $ 2,890  
Direct cost of goods (878) (324) (1,347) (324)  
Sales and marketing costs (2,610) (1,998) (4,877) (3,884)  
Research and development (13,483) (8,407) (21,887) (16,243)  
General and administrative (8,524) (6,637) (16,509) (12,666)  
National Expenses 73,890 17,366 136,149 33,117  
Segment loss from operations (23,193) (15,136) (40,770) (30,227)  
Segment assets 249,846 98,062 249,846 98,062 $ 170,731
Dermatology Products Sales [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 4,054 982 6,139 1,364  
Direct cost of goods (878) (324) (1,347) (324)  
Sales and marketing costs (2,610) (1,998) (4,877) (3,884)  
Research and development 0 0 0 0  
General and administrative (293) 0 (612) 0  
National Expenses 0   0    
Segment loss from operations 273 (1,340) (697) (2,844)  
Segment assets 5,447 3,058 5,447 3,058  
Pharmaceutical And Biotechnology Product Development [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 350 1,248 1,043 1,526  
Direct cost of goods 0 0 0 0  
Sales and marketing costs 0 0 0 0  
Research and development (13,483) (8,407) (21,887) (16,243)  
General and administrative (8,231) (6,637) (15,897) (12,666)  
National Expenses 0   0    
Segment loss from operations (21,364) (13,796) (36,741) (27,383)  
Segment assets 167,787 $ 95,004 167,787 $ 95,004  
Consolidated [Member]          
Segment Reporting Information [Line Items]          
Segment loss from operations     (40,770)    
National [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 46,293   88,197    
Direct cost of goods 0   0    
Sales and marketing costs 0   0    
Research and development 0   0    
General and administrative 0   0    
National Expenses (48,395)   (91,529)    
Segment loss from operations (2,102)   (3,332)    
Segment assets $ 76,612   $ 76,612